QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
7.64B
Market cap7.64B
Price-Earnings ratio
19.33
Price-Earnings ratio19.33
Dividend yield
0.70%
Dividend yield0.70%
Average volume
2.37M
Average volume2.37M
High today
$37.18
High today$37.18
Low today
$36.80
Low today$36.80
Open price
$36.97
Open price$36.97
Volume
1.89M
Volume1.89M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

The current QIAGEN(QGEN) stock price is $37.06, with a market capitalization of 7.64B. The stock trades at a price-to-earnings (P/E) ratio of 19.33 and offers a dividend yield of 70.3%.

As of 2026-06-12, QIAGEN(QGEN) stock has fluctuated between $36.80 and $37.18. The current price stands at $37.06, placing the stock +0.7% above today's low and -0.3% off the high.

The QIAGEN(QGEN)'s current trading volume is 1.89M, compared to an average daily volume of 2.37M.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

QGEN News

TipRanks 3h
Norges Bank Discloses 2.59% Stake in Qiagen

An update from Qiagen ( (QGEN) ) is now available. Qiagen disclosed that Norway’s central bank, Norges Bank, has notified the Dutch financial markets authority...

Simply Wall St 7d
Evaluating Qiagen After New Bundibugyo Ebolavirus Digital PCR Assays Catch Investor Attention

Advertisement Why Qiagen’s new Bundibugyo ebolavirus assays caught the market’s attention Qiagen (QGEN) recently announced research use digital PCR assays for...

Evaluating Qiagen After New Bundibugyo Ebolavirus Digital PCR Assays Catch Investor Attention

Analyst ratings

55%

of 20 ratings
Buy
45%
Hold
55%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.